Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe

Autor: Luis Alberto García Rodríguez, Montse Soriano-Gabarró, Pareen Vora, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Ana Ruigomez, Leif Friberg, Ron Herings, Karin M A Swart, Tania Schink, Elisabeth Smits, Annemarie Voss, Christine Tarenz, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya

Publikováno v: BMJ Open, Vol 14, Iss 3 (2024)

Objectives To describe opportunities and challenges experienced from the four pharmacoepidemiological database studies included in the rivaroxaban post authorisation safety study (PASS) programme and propose ways to maximise the value of population-b

Externí odkaz: https://doaj.org/article/71cd625a0f2244c3a4bb82474e3418be

Safety and effectiveness of appropriately and inappropriately dosed rivaroxaban or apixaban versus warfarin in patients with atrial fibrillation: a cohort study with nested case–control analyses from UK primary care

Autor: Luis Alberto García Rodríguez, Pareen Vora, Luke Roberts, Gunnar Brobert, Samuel Fatoba, María Eugenia Sáez, Antonio González-Pérez

Publikováno v: BMJ Open, Vol 12, Iss 6 (2022)

Externí odkaz: https://doaj.org/article/32d4d86ecd8e4df7aa2725edd2fc8029

Chicamocha canyon wind energy potential and VAWT airfoil selection through CFD modeling

Autor: Luis Fernando García Rodríguez, Julian Ernesto Jaramillo, Jorge Luis Chacón Velasco

Publikováno v: Revista Facultad de Ingeniería Universidad de Antioquia, Iss 94, Pp 56-66 (2019)

The use of vertical axis wind turbines (VAWT) in Colombia could tackle the energy distribution difficulties as large parts of the territory are not connected to the electrical grid. The present research experimentally determines the wind resource ava

Externí odkaz: https://doaj.org/article/b9a9c618363d42e59aec7c2efe484917

Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries

Autor: Luis Alberto García Rodríguez, Ana Ruigómez, Tania Schink, Annemarie Voss, Elisabeth Smits, Karin M. A. Swart, Yanina Balabanova, Kiliana Suzart-Woischnik, Gunnar Brobert, Ron M. C. Herings

Publikováno v: García-Rodríguez, L A, Ruigómez, A, Schink, T, Voss, A, Smits, E, Swart, K M A, Balabanova, Y, Suzart-Woischnik, K, Brobert, G & Herings, R M C 2023, ' Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation : analysis of routine clinical data from four countries ', Expert opinion on drug safety . https://doi.org/10.1080/14740338.2023.2181334
Expert opinion on drug safety. Taylor and Francis Ltd.

Background: The safety and effectiveness of rivaroxaban versus vitamin K antagonists (standard of care [SOC]) for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) was evaluated in Europe. Research design and methods: Observat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cca27dc1f96c0361f2e9c0a5ea231d0e
https://doi.org/10.1080/14740338.2023.2181334

Feasibility and validity of The Health Improvement Network database of primary care electronic health records to identify and characterise patients with small cell lung cancer in the United Kingdom

Autor: Lucía Cea Soriano, Jihong Zong, Luis A. García Rodríguez

Publikováno v: BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)

Abstract Background Epidemiological research on small cell lung cancer (SCLC) is limited and based on cancer registry data. We evaluated the feasibility and validity of using primary care electronic health records (The Health Improvement Network [THI

Externí odkaz: https://doaj.org/article/aef7d33cf3c6473bac0fcebcffc33983